Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_assertion type Assertion NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_head.
- NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_assertion description "[Genomic alterations influencing the expression and/or activity of tumor suppressors or oncogenes such as KRAS2, CDKN2A, TP53, and DPC4 have been directly implicated in the initiation and progression of human pancreatic adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_provenance.
- NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_assertion evidence source_evidence_literature NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_provenance.
- NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_assertion SIO_000772 15929091 NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_provenance.
- NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_assertion wasDerivedFrom befree-20140225 NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_provenance.
- NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_assertion wasGeneratedBy ECO_0000203 NP308532.RAvTu5rEcwnJtxs60PNMGieQS8qOgo0d9uz_ITY_xANMo130_provenance.